ZYNYZ (retifanlimab-dlwr) injection

ZYNYZ is a prescription medicine used to treat a type of skin cancer called Merkel cell carcinoma in adults. ZYNYZ may be used to treat your skin cancer when it has spread or returned. It is not known if ZYNYZ is safe and effective in children.

Home | retifanlimab-dlwr Injection

ZYNYZ (retifanlimab-dlwr) injection Price In India Ahmedabad Bengaluru Chennai Kolkata Mumbai
ZYNYZ (retifanlimab-dlwr) injection

Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!

For Indian Patient Enquiry under NPP.

For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.

ZYNYZ (retifanlimab-dlwr) injection

Retifanlimab is indicated for the treatment of adult patients with metastatic or recurrent locally advanced Merkel cell carcinoma.

ZYNYZ is a programmed death receptor-1 (PD-1)–blocking antibody
indicated for the treatment of adult patients with metastatic or recurrent
locally advanced Merkel cell carcinoma.

Retifanlimab-dlwr is a type of drug called an immune checkpoint inhibitor. It works by binding to the protein PD-1 on the surface of certain immune cells called T cells, which keeps cancer cells from suppressing the immune system. This allows the immune system to attack the cancer cells.

Drug (Brand / Generic): ZYNYZ  / retifanlimab-dlwr
Current Indication: treat Skin Cancer
Approval Date: 2023

Injection: 500 mg/20 mL (25 mg/mL) solution in a single-dose vial.

For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here

Alleviare Life Sciences

About Us

Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.

Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.

Alleviare India, a certified pharmaceutical facilitator / supplier / importer of specialty medicines or drugs based in India.